Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development.
Autor: | Steeghs, Neeltje1 (AUTHOR), Hansen, Aaron R.2 (AUTHOR), Hanna, Glenn J.3,4 (AUTHOR), Garralda, Elena5 (AUTHOR), Park, Haeseong6 (AUTHOR), Strauss, James7 (AUTHOR), Adam, Michael8 (AUTHOR), Campbell, Gossett8 (AUTHOR), Carver, Jennifer8 (AUTHOR), Easton, Rachael8 (AUTHOR), Mays, Katherine8 (AUTHOR), Skrdla, Peter8 (AUTHOR), Struemper, Herbert9 (AUTHOR), Washburn, Michael L.8 (AUTHOR), Matheny, Christopher8 (AUTHOR), Piha‐Paul, Sarina A.10 (AUTHOR) spihapau@mdanderson.org |
---|---|
Zdroj: | CTS: Clinical & Translational Science. Nov2022, Vol. 15 Issue 11, p2625-2639. 15p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |